Detalhe da pesquisa
1.
MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology.
Mod Pathol
; 36(4): 100088, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788087
2.
High False-Positive Rate of (1,3)-ß-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies.
Clin Infect Dis
; 75(2): 330-333, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996098
3.
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia.
Ann Hematol
; 100(1): 63-78, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556451
4.
[Hematology in the time of COVID-19]. / L'hématologie au temps du COVID-19.
Rev Med Suisse
; 16(N° 691-2): 823-826, 2020 Apr 29.
Artigo
em Francês
| MEDLINE | ID: mdl-32348044
5.
Ten-year single-centre experience in fertility preservation of 459 patients suffering from acute leukaemia.
Br J Haematol
; 184(6): 969-973, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30592029
6.
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Blood
; 129(12): 1636-1645, 2017 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049642
7.
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Haematologica
; 108(1): 234-239, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073517
8.
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Haematologica
; 103(12): 2033-2039, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026341
9.
Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia.
Am J Hematol
; 97(3): E91-E93, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904741
10.
Progressive Organ Failure After Ingestion of Wild Garlic Juice.
J Emerg Med
; 50(1): 55-60, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26281812
11.
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
Cancer
; 121(14): 2393-9, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845577
12.
Reversible granulocyte abnormalities after accidental ingestion of Colchicum autumnale.
Blood
; 130(1): 95, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28684450
13.
Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia.
Cell Death Discov
; 10(1): 157, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548753
14.
Ezrin-radixin-moesin-binding sequence of PSGL-1 glycoprotein regulates leukocyte rolling on selectins and activation of extracellular signal-regulated kinases.
J Biol Chem
; 287(13): 10693-10702, 2012 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22311979
15.
Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy.
Haematologica
; 103(11): e527-e530, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880612
16.
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).
Haematologica
; 103(11): e519-e521, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794147
17.
Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes.
Hematology
; 28(1): 2180704, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815747
18.
Republication: Targeting PI3KC2ß Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours.
Anticancer Res
; 42(6): 3217-3230, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641277
19.
CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells.
Cancers (Basel)
; 13(21)2021 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771453
20.
Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript.
Biomark Res
; 9(1): 92, 2021 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930453